Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Allogene Therapeutics Inc
(NQ:
ALLO
)
3.510
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 25, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
10
Open
3.510
Bid (Size)
3.400 (5)
Ask (Size)
3.640 (1)
Prev. Close
3.510
Today's Range
3.510 - 3.510
52wk Range
3.480 - 12.21
Shares Outstanding
142,183,418
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Analyst Ratings for Allogene Therapeutics
September 25, 2023
Via
Benzinga
Allogene Therapeutics Announces Participation in September Investor Conference
September 05, 2023
From
Allogene Therapeutics, Inc.
Via
GlobeNewswire
Performance
YTD
-39.06%
-39.06%
1 Month
-7.14%
-7.14%
3 Month
-25.79%
-25.79%
6 Month
-30.22%
-30.22%
1 Year
-67.74%
-67.74%
More News
Read More
The Next Meme Stock: 6 Tickers Leading a Meme Stock Revival
August 18, 2023
Via
MarketBeat
Allogene Therapeutics Appoints Earl Douglas as General Counsel
August 14, 2023
From
Allogene Therapeutics, Inc.
Via
GlobeNewswire
Earnings Outlook For Allogene Therapeutics
August 01, 2023
Via
Benzinga
Analyst Ratings for Allogene Therapeutics
June 16, 2023
Via
Benzinga
Why Allogene Stock Is Trading Down Today
June 14, 2023
Via
Benzinga
Allogene Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
August 02, 2023
From
Allogene Therapeutics, Inc.
Via
GlobeNewswire
3 Stocks With Sky-High Short Interest Levels
July 31, 2023
Via
MarketBeat
Allogene Therapeutics to Report Second Quarter 2023 Financial Results on August 2, 2023
July 26, 2023
From
Allogene Therapeutics, Inc.
Via
GlobeNewswire
Short Squeeze Alert: The 5 Most Shorted Stocks Right Now
June 22, 2023
Via
InvestorPlace
Where Allogene Therapeutics Stands With Analysts
May 26, 2023
Via
Benzinga
Allogene Therapeutics' Allogeneic CAR-T Therapy Proves Potential for LBCL Treatment, Analysts See Potential for First-in-Class Status
June 16, 2023
Via
Benzinga
Allogene Therapeutics Provides Additional ALLO-501/501A Phase 1 Data in an Oral Presentation at the International Conference on Malignant Lymphoma (ICML) Lugano
June 15, 2023
From
Allogene Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 14, 2023
Via
Benzinga
Allogene Therapeutics Announces Departure of Chief Financial Officer
June 14, 2023
From
Allogene Therapeutics, Inc.
Via
GlobeNewswire
Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 14, 2023
Via
Benzinga
Allogene Therapeutics Announces Oral Presentation of Phase 1 Data on ALLO-501/501A in Large B Cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) Lugano
June 09, 2023
From
Allogene Therapeutics, Inc.
Via
GlobeNewswire
Allogene Therapeutics Presents Updated ALLO-501/501A Phase 1 Data in Large B Cell Lymphoma at the American Society of Clinical Oncology (ASCO) Annual Meeting
June 03, 2023
From
Allogene Therapeutics, Inc.
Via
GlobeNewswire
Allogene Therapeutics Announces Participation in Three Upcoming Investor Conferences
May 24, 2023
From
Allogene Therapeutics, Inc.
Via
GlobeNewswire
The 3 Best Stocks to Short in May 2023
May 19, 2023
Via
InvestorPlace
7 Short-Interest Stocks to Target for Explosive Gains
May 18, 2023
Via
InvestorPlace
As Feinstein Returns To Congress, Reports Of Her Stock Profits Upset Aaron Rodgers
May 15, 2023
Via
Benzinga
Allogene Therapeutics Announces Encore Presentation of Phase 1 Data from the ALLO-501/501A Trials in Large B Cell Lymphoma at the European Hematology Association (EHA) Hybrid Congress
May 11, 2023
From
Allogene Therapeutics, Inc.
Via
GlobeNewswire
Why Synaptics Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
May 04, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.